489 related articles for article (PubMed ID: 24981117)
1. Risk factors for tracheobronchial acquisition of resistant Gram-negative bacterial pathogens in mechanically ventilated ICU patients.
Papakonstantinou I; Angelopoulos E; Baraboutis I; Perivolioti E; Parisi M; Psaroudaki Z; Kampisiouli E; Argyropoulou A; Nanas S; Routsi C
J Chemother; 2015 Oct; 27(5):283-9. PubMed ID: 24981117
[TBL] [Abstract][Full Text] [Related]
2. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit.
Nseir S; Blazejewski C; Lubret R; Wallet F; Courcol R; Durocher A
Clin Microbiol Infect; 2011 Aug; 17(8):1201-8. PubMed ID: 21054665
[TBL] [Abstract][Full Text] [Related]
3. Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study.
Siwakoti S; Subedi A; Sharma A; Baral R; Bhattarai NR; Khanal B
Antimicrob Resist Infect Control; 2018; 7():114. PubMed ID: 30275945
[TBL] [Abstract][Full Text] [Related]
4. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
5. Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit.
Maina JW; Mutua JM; Musyoki AM
BMC Infect Dis; 2024 May; 24(1):522. PubMed ID: 38783175
[TBL] [Abstract][Full Text] [Related]
6. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
Vasudevan A; Mukhopadhyay A; Li J; Yuen EG; Tambyah PA
BMC Infect Dis; 2014 Nov; 14():615. PubMed ID: 25420613
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
8. ICU Pathogens: A Continuous Challenge.
Hafeez A; Munir T; Najeeb S; Rehman S; Gilani M; Ansari M; Saad N
J Coll Physicians Surg Pak; 2016 Jul; 26(7):577-80. PubMed ID: 27504548
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections.
Akinci E; Colpan A; Bodur H; Balaban N; Erbay A
J Hosp Infect; 2005 Apr; 59(4):317-23. PubMed ID: 15749320
[TBL] [Abstract][Full Text] [Related]
10. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
[TBL] [Abstract][Full Text] [Related]
11. Multidrug-resistant gram-negative bacterial infections after liver transplantation - spectrum and risk factors.
Zhong L; Men TY; Li H; Peng ZH; Gu Y; Ding X; Xing TH; Fan JW
J Infect; 2012 Mar; 64(3):299-310. PubMed ID: 22198738
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections.
Gomila A; Shaw E; Carratalà J; Leibovici L; Tebé C; Wiegand I; Vallejo-Torres L; Vigo JM; Morris S; Stoddart M; Grier S; Vank C; Cuperus N; Van den Heuvel L; Eliakim-Raz N; Vuong C; MacGowan A; Addy I; Pujol M;
Antimicrob Resist Infect Control; 2018; 7():111. PubMed ID: 30220999
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with resistance to ciprofloxacin in clinical bacterial isolates from intensive care unit patients.
Levin PD; Fowler RA; Guest C; Sibbald WJ; Kiss A; Simor AE
Infect Control Hosp Epidemiol; 2007 Mar; 28(3):331-6. PubMed ID: 17326025
[TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units.
Wroblewska MM; Rudnicka J; Marchel H; Luczak M
Int J Antimicrob Agents; 2006 Apr; 27(4):285-9. PubMed ID: 16545949
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Multidrug-Resistant Organism Among Children Admitted to Pediatric Intensive Care Unit in a Developing Country.
El-Nawawy A; Ashraf GA; Antonios MAM; Meheissen MA; El-Alfy MMR
Microb Drug Resist; 2018 Oct; 24(8):1198-1206. PubMed ID: 29589993
[TBL] [Abstract][Full Text] [Related]
16. Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia.
Verhamme KM; De Coster W; De Roo L; De Beenhouwer H; Nollet G; Verbeke J; Demeyer I; Jordens P
Infect Control Hosp Epidemiol; 2007 Apr; 28(4):389-97. PubMed ID: 17385143
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008.
Kallen AJ; Hidron AI; Patel J; Srinivasan A
Infect Control Hosp Epidemiol; 2010 May; 31(5):528-31. PubMed ID: 20334552
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial.
Bertrand X; Dowzicky MJ
Clin Ther; 2012 Jan; 34(1):124-37. PubMed ID: 22154196
[TBL] [Abstract][Full Text] [Related]
19. Frequency and predictors of colonization of the respiratory tract by VIM-2-producing Pseudomonas aeruginosa in patients of a newly established intensive care unit.
Horianopoulou M; Legakis NJ; Kanellopoulou M; Lambropoulos S; Tsakris A; Falagas ME
J Med Microbiol; 2006 Oct; 55(Pt 10):1435-1439. PubMed ID: 17005794
[TBL] [Abstract][Full Text] [Related]
20. Impact of a hospital-wide antimicrobial formulary intervention on the incidence of multidrug-resistant gram-negative bacteria.
Furtado GH; Perdiz LB; Santana IL; Camargo MM; Parreira FC; Angelieri DB; Medeiros EA
Am J Infect Control; 2008 Nov; 36(9):661-4. PubMed ID: 18834728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
